Global law firm, White & Case, in collaboration with The Law Office of Megren M. Al-Shaalan, has provided legal counsel in the initial public offering (IPO) of Jamjoom Pharmaceuticals Factory Company (Jamjoom). Saudi Fransi Capital and J.P. Morgan Saudi Arabia Company served as joint financial advisors, joint bookrunners, and joint underwriters, with Saudi Fransi Capital […]
Clifford Chance on €45M financing of GZT Healthcare Investment
International law firm Clifford Chance advised Invest International with the EUR 45 million financing of GZT Healthcare Investment, a subsidiary of Rönesans Holding, in connection with the Gaziantep City Hospital, a public private partnership in
Clifford Chance advises M42 on its acquisition of Diaverum
International law firm Clifford Chance is advising M42, an Abu Dhabi-based tech-enabled healthcare company in connection with is acquisition of the entire share capital of Diaverum from Bridgepoint Group. A transaction that will see M42
Asafo & Co.: MCP in strategic investment agreement with Laprophan
Asafo & Co. provided advisory services to Mediterrania Capital Partners (‘MCP’) as it spearheaded a consortium to execute a strategic investment agreement with Laprophan, a prominent pharmaceuticals entity in Morocco. MCP, a private equity firm
B Investments and TSFE invest in Egypt’s healthcare sector
The Sovereign Fund of Egypt (“TSFE”) through its healthcare and pharmaceutical industries Subfund (“TSFE Healthcare & Pharma Subfund”) and B Investments Holding (“B Investments”), BPE Partners’ flagship investment vehicle, have signed an agreement to
Sandoz Egypt Pharma signs new partnership with Ibnsina Pharma
Sandoz Egypt Pharma, a division of the Novartis Group, and Ibnsina Pharma, a pharmaceutical distribution company, have partnered to expand access to Sandoz’s over-the-counter (OTC) portfolio of products through a distribution and
Asafo & Co. advises in Moroccan private hospital group Akdital’s IPO
Asafo & Co. is advising Akdital in its IPO on the Casablanca Stock Exchange. The offering will take place through a capital increase and a share sale. Valued at 1.2 billion dirhams (US$ 110 million),
Burjeel Holdings opens subscription period for IPO in UAE
Burjeel Holdings has announced the offer price range and the opening of the subscription period for its Initial Public Offering (IPO) on the Abu Dhabi Securities Exchange (ADX). The opening of the subscription period
Trowers & Hamlins: RCSI Bahrain launches new solar farm project
The Royal College of Surgeons in Ireland – Medical University of Bahrain (“RCSI Bahrain”) has successfully completed the development and launch of its campus solar farm project. Covering 12,000 sqm, the solar farm is expected to be
GSK Group completes demerger of Haleon Group. The advisors
Global healthcare company GlaxoSmithKline Services Unlimited (“GSK Group”) has completed the demerger of its consumer healthcare business to form global consumer healthcare company Haleon Group. The transaction was valued at GBP 55 million (approximately USD 63.8 million).